Lars Hansen

1.1k total citations
32 papers, 829 citations indexed

About

Lars Hansen is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Lars Hansen has authored 32 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Surgery and 12 papers in Molecular Biology. Recurrent topics in Lars Hansen's work include Pancreatic function and diabetes (11 papers), Diabetes Management and Research (9 papers) and Diabetes Treatment and Management (9 papers). Lars Hansen is often cited by papers focused on Pancreatic function and diabetes (11 papers), Diabetes Management and Research (9 papers) and Diabetes Treatment and Management (9 papers). Lars Hansen collaborates with scholars based in Denmark, United States and Sweden. Lars Hansen's co-authors include Oluf Pedersen, Henrik B. Mortensen, Lotte B. Nielsen, Philip Hougaard, Flemming Pociot, Niels‐Erik Larsen, Cheng Wang, Kaspar Sørensen, Chen‐Yu Zhang and Anders Juul and has published in prestigious journals such as PLoS ONE, Diabetes and Human Molecular Genetics.

In The Last Decade

Lars Hansen

31 papers receiving 801 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lars Hansen Denmark	14	360	285	279	233	180	32	829
Yuedan Zhou Sweden	12	292 0.8×	161 0.6×	124 0.4×	210 0.9×	39 0.2×	18	582
Behrous Davani Sweden	8	180 0.5×	288 1.0×	333 1.2×	191 0.8×	19 0.1×	8	670
M. Bouisson France	15	278 0.8×	227 0.8×	52 0.2×	62 0.3×	161 0.9×	27	704
H Gröbe Germany	11	237 0.7×	109 0.4×	195 0.7×	160 0.7×	25 0.1×	30	680
Caterina Formichi Italy	17	275 0.8×	184 0.6×	219 0.8×	115 0.5×	216 1.2×	27	731
Laurence E. Stout United States	14	276 0.8×	376 1.3×	245 0.9×	213 0.9×	25 0.1×	16	745
F. Ichikawa Japan	10	261 0.7×	201 0.7×	164 0.6×	198 0.8×	20 0.1×	11	640
Dianne Deplewski United States	12	457 1.3×	45 0.2×	132 0.5×	76 0.3×	75 0.4×	23	1.2k
Haibo Xue China	16	177 0.5×	38 0.1×	235 0.8×	64 0.3×	104 0.6×	38	785
Emilia Ottosson-Laakso Sweden	8	233 0.6×	251 0.9×	154 0.6×	182 0.8×	22 0.1×	11	492

Countries citing papers authored by Lars Hansen

Since Specialization

Citations

This map shows the geographic impact of Lars Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Hansen more than expected).

Fields of papers citing papers by Lars Hansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Hansen. The network helps show where Lars Hansen may publish in the future.

Co-authorship network of co-authors of Lars Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Hansen. A scholar is included among the top collaborators of Lars Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Hansen. Lars Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Parker, Victoria, Lars Hansen, Darren Robertson, et al.. (2025). Pharmacokinetic‐pharmacodynamic (PK/PD) modelling of cotadutide effect in patients with chronic kidney disease and type 2 diabetes mellitus. British Journal of Clinical Pharmacology. 91(9). 2672–2683.

Ueckert, Sebastian, Lina Zhou, Jenny Cheng, et al.. (2024). Exposure–response modeling for nausea incidence for cotadutide using a Markov modeling approach. CPT Pharmacometrics & Systems Pharmacology. 13(9). 1582–1594. 2 indexed citations

Golubić, Rajna, Jane Kennet, Victoria Parker, et al.. (2024). Dual glucagon‐like peptide ‐1 and glucagon receptor agonism reduces energy intake in type 2 diabetes with obesity. Diabetes Obesity and Metabolism. 26(7). 2634–2644. 9 indexed citations

Klein, G., et al.. (2023). Pharmacokinetics and Safety of Cotadutide, a GLP-1 and Glucagon Receptor Dual Agonist, in Individuals with Renal Impairment: A Single-Dose, Phase I, Bridging Study. Clinical Pharmacokinetics. 62(6). 881–890. 4 indexed citations

Parker, Victoria, Darren Robertson, Bas Havekes, et al.. (2023). Cotadutide promotes glycogenolysis in people with overweight or obesity diagnosed with type 2 diabetes. Nature Metabolism. 5(12). 2086–2093. 35 indexed citations

Robertson, Darren, Lars Hansen, Lutz Jermutus, et al.. (2023). #3000 EFFICACY AND SAFETY OF COTADUTIDE, A DUAL GLP1-GLUCAGON RECEPTOR AGONIST, IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND T2DM. Nephrology Dialysis Transplantation. 38(Supplement_1). 1 indexed citations

Parker, Victoria, Heike Schlichthaar, Fraser W. Gibb, et al.. (2022). Efficacy and safety of cotadutide, a dual glucagon‐like peptide‐1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease. Diabetes Obesity and Metabolism. 24(7). 1360–1369. 56 indexed citations

Fredheim, Siri, Sven Pörksen, Lotte B. Nielsen, et al.. (2014). The influence of glucagon on postprandial hyperglycaemia in children 5 years after onset of type 1 diabetes. Diabetologia. 58(4). 828–834. 29 indexed citations

Rasmussen, Morten Arendt, Sven Pörksen, Jannet Svensson, et al.. (2013). Complex Multi-Block Analysis Identifies New Immunologic and Genetic Disease Progression Patterns Associated with the Residual β-Cell Function 1 Year after Diagnosis of Type 1 Diabetes. PLoS ONE. 8(6). e64632–e64632. 18 indexed citations

10.

Nielsen, Lotte B., Jannet Svensson, Sven Pörksen, et al.. (2013). Disease progression among 446 children with newly diagnosed type 1 diabetes located in Scandinavia, Europe, and North America during the last 27 yr. Pediatric Diabetes. 15(5). 345–354. 12 indexed citations

11.

Vaziri‐Sani, Fariba, Sven Pörksen, Jane Thomsen, et al.. (2012). Association between autoantibodies to the Arginine variant of the Zinc transporter 8 (ZnT8) and stimulated C-peptide levels in Danish children and adolescents with newly diagnosed type 1 diabetes. Pediatric Diabetes. 13(6). 454–462. 20 indexed citations

12.

Nielsen, Lotte B., Cheng Wang, Kaspar Sørensen, et al.. (2012). Circulating Levels of MicroRNA from Children with Newly Diagnosed Type 1 Diabetes and Healthy Controls: Evidence That miR-25 Associates to Residual Beta-Cell Function and Glycaemic Control during Disease Progression. Experimental Diabetes Research. 2012. 1–7. 238 indexed citations

13.

Pörksen, Sven, Lotte B. Nielsen, Jesper Johannesen, et al.. (2010). Analyses of the rate of decline in stimulated c-peptide 12 months after diagnosis in children with newly diag-nosed type 1 diabetes. results from the Hvidoere study group on childhood diabetes. Pediatric Diabetes. 1 indexed citations

14.

Nielsen, Eva-Maria D., Lars Hansen, Maria Lajer, et al.. (2004). A common polymorphism in the promoter of the IGF-I gene associates with increased fasting serum triglyceride levels in glucose-tolerant subjects. Clinical Biochemistry. 37(8). 660–665. 9 indexed citations

15.

Hansen, Lars & Oluf Pedersen. (2004). Genetics of type 2 diabetes mellitus: status and perspectives. Diabetes Obesity and Metabolism. 7(2). 122–135. 43 indexed citations

16.

Hansen, Lars. (2003). Candidate genes and late-onset type 2 diabetes mellitus. Susceptibility genes or common polymorphisms?. PubMed. 50(4). 320–46. 13 indexed citations

17.

Hansen, Lars, Björn Zethelius, Lars Berglund, et al.. (2001). In Vitro and In Vivo Studies of a Naturally Occurring Variant of the Human p85α Regulatory Subunit of the Phosphoinositide 3-Kinase. Diabetes. 50(3). 690–693. 21 indexed citations

18.

Hansen, Lars, Torben Hansen, Henrik Vestergaard, et al.. (1995). A widespread amino acid polymorphism at codon 905 of the glycogen-associated regulatory subunit of protein phosphatase-1 is associated with insulin resistance and hypersecretion of insulin. Human Molecular Genetics. 4(8). 1313–1320. 73 indexed citations

19.

Larsen, Niels‐Erik & Lars Hansen. (1989). Prediction of the Optimal Perphenazine Decanoate Dose Based on Blood Samples Drawn Within the First Three Weeks. Therapeutic Drug Monitoring. 11(6). 642–646. 7 indexed citations

20.

Hansen, Lars & Niels‐Erik Larsen. (1977). Plasma concentrations of perphenazine and its sulphoxide metabolite during continuous oral treatment. Psychopharmacology. 53(2). 127–130. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact